Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Big Pharma Frustration with Physician Dispensing


News provided by

Physician Dispensing Association

Aug 04, 2017, 10:50 ET

Share this article

Share toX

Share this article

Share toX

BOCA RATON, Fla., Aug. 4, 2017 /PRNewswire/ -- The following article by Anthony Phillips President of the Physician Dispensing Association discusses attempts by a multinational pharmaceutical company to undermine physician dispensing.

How do you know when your innovation is on the right track? One good indication may be found in the reaction you receive from the protectors of the paradigm you're trying to disrupt. I recently was made aware of a real-life example of this that just happened just this past weekend.

I was saddened to hear that at this year's American Academy of Dermatology (AAD) Sumer Meeting in New York, a large, well known, multinational pharmaceutical company was heard publicly "slinging mud" at one of the industry's most exciting innovators. I am also reassured though that this is a good indication the innovator is changing things for the better. To make big pharma so concerned that their only resort is to turn around and slap the new kid on the block you must be doing something right!

There is no doubt It has been a rough past few years for big pharma. Headline after headline highlighting blatant industry-wide greed that pop-up seemingly on a weekly basis. Not only have their CEOs been taking a public shaming over price gouging, they have also introduced little-to-no new innovations or products.

In the article, The Public's View of Pharma Just Keeps Getting Worse published August 30th, Ed Silverman said, "Of 25 different business sectors, only the federal government is held in lower esteem by most Americans, according to a recent Gallup Poll." Could all the recent bad press and public criticism have anything to do with it?

Who was this company that earned the exasperation of a pharmaceutical giant? The company under attack is one whose members I have worked closely with for the past two years, Prescriber's Choice. Prescriber's Choice and its physician members have quietly but effectively been addressing some of the biggest issues in our healthcare model. Prescriber's Choice was founded on three core principles:

  1. Enhance Patient Understanding
  2. Increase Patient Compliance
  3. Improve Patient Outcomes

This type of regard for our medical practitioners and their patients has been something painfully absent from the recent landscape of the pharmaceutical industry. This brings no surprise that this could make a company like Prescriber's Choice fall into the cross hairs of a pharmaceutical goliaths who have been putting profits over needs for some time now.

Our PDA members that use Prescriber's Choice are seeing amazing results from implementing the model into their practice. Most of them are dermatologists. The field of dermatology has been uniquely affected by recent price spikes in the industry, and reductions in insurance coverage.

Physicians love the point-of-care service because of how it has given them back the ability to practice medicine the way it was meant to be practiced. The patients see new hope in their prescription availability as physicians are providing custom-tailored medications directly to their patients, from the point of care. These medications are typically provided for less than the average specialty co-pay in a pharmacy. We asked some of our members what using Prescriber's Choice meant to them and their patients.

"Having the ability to custom formulate dermatology prescriptions that are both effective and economical for my patients, has been professionally gratifying and extremely empowering." - Julie Kenner MD PhD

"In office dispensing through Prescriber's Choice has helped alleviate the frustrations of our patients not being able to get the medications we want them to have due to cost or barriers from insurance companies." - Dr. Jerome Potozkin

"Prescriber's Choice allows me and my team the freedom to prescribe prescription medications based upon the patient's diagnosis and their needs without the limitations of insurance coverage, high cost or "special" access to mail order pharmacies.  My patients obtain their medication immediately at the time of their appointment. Affordability is paramount and retail pharmaceuticals carry untenable costs.  "Special" cards to defray this cost are specious as they charge insurance high fees for which we all ultimately pay. Prior Authorizations frequently fail and they consume valuable time while increasing frustration from patient and provider alike. Prescriber's Choice provides medications from an US based, FDA facility and my patients regularly obtain excellent results" – Carla Bauman, MD

"With the changing landscape of healthcare, essential and important medications are becoming harder for patients to obtain. Rising costs and decreasing coverage are problematic. As a physician, I have seen this first hand and I spend a large part of my day in the decision-making process of how to get patients medications and wondering if they will be covered. My staff and I spend excessive amounts of time determining what specialty pharmacies dispense what medications, if a coupon is available, filling out prior authorizations and then we end up speculating if the patient will even get the medication. This situation is a burden to my staff, me and most importantly, my patients. Since discovering and using Prescriber's Choice, I have been able to save my patients time and money and it is reassuring knowing that the patient has the medication they need when they leave my office. I have been incredibly happy with in-office dispensing thus far and am planning to expand the medications I carry in my office."  - James C. Collyer, MD,

It is notable that these physicians have even taken additional steps to become an accredited practice through The Physician Dispensing Association, demonstrating that they meet the highest quality standards and state and federal regulations for dispensing medication outside of a pharmacy setting.

Yes, innovation brings the inevitable "break-the-rules" backlash, but is Prescriber's Choice breaking any actual rules? They are not. How do I know this? I know because we (The Physician Dispensing Association) have reviewed their model and its implementation by its physician members. We have carefully reviewed state by state the requirements to audit this physician dispensing platform. But that's not all.   

Prescriber's Choice has also received a memorandum on its model demonstrating their validity and legitimacy from Ropes & Gray LLP, a preeminent global law firm, with more than 1200 legal professionals serving clients in business, technology, and government. Something that goes completely contrary to the street level defamation and innuendo our unnamed pharma giant has resorted to.

We do not have to accept the things we are not ok with, and that is where change and innovation take off. And while I am saddened to see such a poor reaction from such a large company, I am also convinced that Prescriber's Choice is on the right track to fixing inefficiencies in our healthcare system.

Progress is impossible without change and healthcare is due for progress. What more noble cause could a movement represent than to enhance patient understanding, increase compliance and improve outcomes? It's time we put needs before profits and see our healthcare system thrive. As we go forward we should expect more backlash from the old guard as positive change comes about.

Contact:

Anthony Phillips
[email protected]
888-510-8009

SOURCE Physician Dispensing Association

Related Links

http://www.physiciandispense.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.